• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC141400
Device Problems Unintended Collision (1429); Difficult to Remove (1528); Material Separation (1562); Difficult to Advance (2920)
Patient Problem No Code Available (3191)
Event Date 05/15/2014
Event Type  Injury  
Event Description
On (b)(6) 2014, the patient underwent treatment of a 9cm abdominal aortic aneurysm with a system of gore excluder aaa endoprostheses.It was reported the patient had a short (<15 mm) angulated proximal neck (exact measurements not given).As it was reported the patient¿s right kidney was atrophied prior to the procedure, the physician elected to intentionally cover the right renal artery and perform a snorkel procedure into the left renal artery.A brachial approach was utilized to implant a 6mm x 5cm gore viabahn endoprosthesis in to the left renal artery.It was reported full patency was established to the patient¿s left renal artery after completion of the snorkel procedure.Access was then obtained through the left femoral artery, whereby the trunk-ipsilateral leg component was deployed distal to the superior mesenteric artery.A contralateral leg component was implanted to provide distal extension into the left common iliac artery.Touch up ballooning was performed and it was reported all devices were implanted without issue.It was reported that the 12 fr gore dryseal sheath with hydrophilic coating being used was not long enough to reach the contralateral gate of the trunk, so the sheath was positioned distal to the gate.The contralateral leg component was advanced outside of the sheath to the level of the contralateral gate, but would not advance into the gate.It was reported the cause of the resistance during advancement of the device into the contralateral gate was due to the contralateral leg component interacting with the gate.It was reported the contralateral leg component caught on the contralateral gate during positioning.The endoprosthesis was rotated and advanced into the contralateral gate.The graft was advanced just proximal to the level of the flow divider within the trunk.An attempt was made to move the graft distal to the flow divider but this proved unsuccessful as a segment of the deployment line had come out of the delivery catheter causing the contralateral leg component to partially deploy and achieve wall apposition at the leading end of the graft.The contralateral leg component was then fully deployed.An additional guidewire and sheath were advanced through the brachial artery into the contralateral gate insuring additional access should it became necessary to position an additional contralateral limb parallel to the first contralateral leg component.This proved unnecessary as it was determined the contralateral leg component had successfully deployed within the contralateral gate.As the contralateral leg component delivery system was removed, it was noted the leading olive and polyimide remained inside the patient.An attempt was made to withdraw the leading olive and polyimide through a 7fr sheath but it this proved unsuccessful as the components continued to become caught on the tip of the sheath.Access was obtained through the brachial artery and the guidewire was snared.An attempted to withdraw the guidewire, leading olive and polyimide delivery components into the catheter again proved unsuccessful.The snare catheter was repositioned distal to the leading olive.All delivery components were successfully retrieved through the brachial access.The procedure concluded with an additional contralateral leg component deployed to extend distally into the right external iliac artery.Touch up ballooning was performed and final angiography showed resolution of the aneurysm, good proximal and distal seal and no evidence of an endoleak.The patient tolerated the procedure with no further issues noted.
 
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.The root cause of the leading olive and polyimide separation could not be determined with the provided information.
 
Manufacturer Narrative
Evaluation summary - the contralateral leg component was returned to gore for evaluation.During the investigation it was noted the polyimide guidewire lumen had detached at the leading end of the trailing olive junction.It appeared the detachment was due to a polyimide guidewire lumen¿s tensile failure while the trailing olive junction remained intact.Additionally, it was observed the free end of the deployment line did not appear to be clean-cut.The length of the returned segment of the deployment line from the free end of the deployment line to the male luer lock measured 53cm.As compared to the standard measurement of 119 cm.Based on the available information and evaluation of the returned portion of the product, the root cause for the reported deployment line break and the polyimide detachment could not be determined at this time.However, use outside of the ifu was noted and may have contributed to this event.
 
Manufacturer Narrative
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
charlene cooper
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3822039
MDR Text Key18730980
Report Number2953161-2014-00062
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/28/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/20/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2016
Device Catalogue NumberPXC141400
Device Lot Number12087592
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/23/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NOT AVAILABLE.
Patient Outcome(s) Hospitalization; Other;
Patient Age91 YR
Patient Weight66
-
-